Search Results for "Angiotensin (1-7)" - 278 interactions found in 59 entries.

Entry-ID
Interactor1 (Subject) Interaction type Interactor2 (Object) additional information
PubMed-ID
Diseases
2,002
15885 Angiotensin (1-7) decreases_activity of smooth muscle cell proliferation in vascular smooth muscle; if induced by angiotensin II, via MAS1
15886 Angiotensin (1-7) decreases_activity of Angiotensin II in vascular smooth muscle
15890 A-779 decreases_activity of Angiotensin (1-7)
15893 Angiotensin (1-7) NOT increases_activity of smooth muscle cell migration in vascular smooth muscle
15894 Angiotensin (1-7) affects_activity of smooth muscle cell migration in vascular smooth muscle; via inhibition of angiotensin II
15898 Angiotensin (1-7) affects_phosphorylation of MAPK3/1 in vascular smooth muscle; via inhibition of angiotensin II
20808802 Diabetes mellitus, type II
Insulin resistance
2,003
15899 Angiotensin (1-7) decreases_activity of NF-kappaB complex in cardiac muscle
15917 Angiotensin (1-7) decreases_activity of I-kappaB kinase/NF-kappaB signaling in cardiac muscle
15919 Angiotensin (1-7) decreases_expression of TLR2 in cardiac muscle
15920 Angiotensin (1-7) decreases_expression of IRAK1 in cardiac muscle
15921 Angiotensin (1-7) decreases_expression of IKBKB in cardiac muscle
15923 Angiotensin (1-7) decreases_expression of C3 in cardiac muscle
15925 Angiotensin (1-7) decreases_expression of IL1B in cardiac muscle
15926 Angiotensin (1-7) decreases_expression of IL6 in cardiac muscle
15928 Angiotensin (1-7) decreases_expression of NLRP12 in cardiac muscle
15929 Angiotensin (1-7) decreases_expression of CASP1 in cardiac muscle
15931 Angiotensin (1-7) decreases_activity of inflammatory response in cardiac muscle
19166939 Diabetes mellitus, type II
Insulin resistance
9,686
102331 Angiotensin (1-7) increases_quantity of NO in ventricular cardiomyocytes
102333 Angiotensin (1-7) increases_phosphorylation of AKT1 at Ser473
29443552 Cardiovascular disease
9,698
102346 Angiotensin (1-7) increases_quantity of Alamandine
23446738 Cardiovascular disease
11,717
116348 ACE2 increases_quantity of Angiotensin (1-7)
116350 Angiotensin (1-7) affects_activity of insulin secretion
116374 Angiotensin (1-7) affects_activity of MAS1
116377 Angiotensin (1-7) increases_quantity of cAMP in the cell
116434 Angiotensin (1-7) decreases_activity of response to oxidative stress
116435 MME decreases_quantity of Angiotensin (1-7)
30404071 Diabetes mellitus, type II
Insulin resistance
11,748
116367 Angiotensin II increases_quantity of Angiotensin (1-7) via cleavage by ACE2 and other enzymes
116369 ACE2 increases_quantity of Angiotensin (1-7)
116373 Angiotensin (1-7) increases_activity of MAS1
116375 Angiotensin (1-7) increases_quantity of Angiotensin (1-5)
116378 Angiotensin (1-7) increases_activity of AGTR2 but with lower affinity than ANG II
116398 PREP increases_quantity of Angiotensin (1-7)
32333398 COVID-19
11,751
116894 Angiotensin I increases_quantity of Angiotensin (1-7) via catalytic action of MME (NEP)
116895 Angiotensin (1-9) increases_quantity of Angiotensin (1-7) via catalytic action of MME (NEP)
116896 MME increases_quantity of Angiotensin (1-7)
15283675 Endocrine
11,756
116634 Angiotensin (1-7) decreases_activity of inflammatory response in the alveolar microenvironment
32333398 COVID-19
11,758
116447 Angiotensin (1-7) decreases_activity of epithelial to mesenchymal transition in A549 cells
116450 Angiotensin (1-7) decreases_activity of TGFB1 in A549 cells
116452 Angiotensin (1-7) decreases_expression of ZEB1 in A549 cells; via inhibition of TGFbeta1-SMAD signaling
116453 Angiotensin (1-7) decreases_expression of ZEB2 in A549 cells; via inhibition of TGFbeta1-SMAD signaling
116454 Angiotensin (1-7) decreases_expression of TWIST1 in A549 cells; via inhibition of TGFbeta1-SMAD signaling
116455 Angiotensin (1-7) decreases_expression of SNAI1 in A549 cells; via inhibition of TGFbeta1-SMAD signaling
116456 Angiotensin (1-7) affects_activity of MTOR in A549 cells; via inhibition of TGFbeta1-SMAD signaling
31387171 Pulmonary fibrosis, idiopathic
11,776
116574 ACE decreases_quantity of Angiotensin (1-7)
116583 ACE increases_quantity of Angiotensin (1-7)
116585 MME increases_quantity of Angiotensin (1-7)
116587 PREP increases_quantity of Angiotensin (1-7)
116589 ACE2 increases_quantity of Angiotensin (1-7)
116591 PRCP increases_quantity of Angiotensin (1-7)
116592 Angiotensin (1-7) increases_activity of MAS1
116598 Angiotensin (1-7) increases_activity of vasodilation
116600 Angiotensin (1-7) decreases_activity of thrombosis
116601 Angiotensin (1-7) decreases_activity of cell population proliferation
116602 Angiotensin (1-7) increases_quantity of NO in vascular endothelial cells
116604 Angiotensin (1-7) decreases_quantity of Reactive oxygen species in vascular endothelial cells
116605 Angiotensin (1-7) increases_activity of NOS3 in vascular endothelial cells
116606 Angiotensin (1-7) decreases_activity of atherosclerotic lesions
116610 Angiotensin (1-7) decreases_activity of Nephropathy, diabetic
116612 Angiotensin (1-7) affects_activity of renal sodium ion absorption
116614 Angiotensin (1-7) affects_activity of cardiac fibrosis
116624 Angiotensin (1-7) decreases_activity of abnormal circulating lipid level
116625 Angiotensin (1-7) decreases_activity of Insulin resistance
23463883 Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
11,777
116632 embryo development affects_quantity of Angiotensin (1-7)
26029927 Diabetes mellitus, type II
Insulin resistance
11,821
116758 ACE2 increases_quantity of Angiotensin (1-7)
116759 Angiotensin (1-7) increases_activity of MAS1
32341442 COVID-19
11,822
116790 ACE2 increases_quantity of Angiotensin (1-7)
116795 Angiotensin II increases_quantity of Angiotensin (1-7) via the catalytic activity of ACE2
32336612 COVID-19
11,823
116809 ACE2 increases_quantity of Angiotensin (1-7)
116810 Angiotensin II increases_quantity of Angiotensin (1-7) via the action of ACE2
11815627 Metabolic
11,837
116874 ACE increases_quantity of Angiotensin (1-7)
116876 ACE decreases_quantity of Angiotensin (1-7)
116883 Angiotensin (1-7) increases_quantity of Angiotensin (1-5)
116884 Angiotensin (1-9) increases_quantity of Angiotensin (1-7)
10969042 Endocrine
11,842
116927 PRCP increases_quantity of Angiotensin (1-7) in kidney ; at acidic pH
116928 ACE2 increases_quantity of Angiotensin (1-7) in kidney ; at neutral to basic pH
23392115 Endocrine
11,844
116936 THOP1 increases_quantity of Angiotensin (1-7) in hippocampus
116937 Angiotensin I increases_quantity of Angiotensin (1-7) in hippocampus; via the catalytic action of THOP1
24041943 Neurological
11,899
117136 ACE2, soluble increases_quantity of Angiotensin (1-7) in cerebrospinal fluid
28512108 Neurological
SARS-CoV infection
11,908
117213 Angiotensin (1-7) increases_activity of AGTR2 if candesartan is coadministered
117214 Angiotensin (1-7) decreases_activity of hypertension if candesartan is coadministered
117217 Candesartan affects_activity of Angiotensin (1-7)
15767466 Cardiovascular disease
11,918
117246 Angiotensin (1-7) increases_quantity of Atrial natriuretic peptide in atrium
27660028 Cardiovascular disease
11,922
117257 Angiotensin (1-7) increases_activity of MAS1 in LPS plus IFNG-stimulated macrophages
117270 Angiotensin (1-7) decreases_expression of TNF in LPS plus IFNG-stimulated macrophages; via MAS1
117272 Angiotensin (1-7) decreases_expression of CCL2 in LPS plus IFNG-stimulated macrophages; via MAS1
117274 Angiotensin (1-7) decreases_expression of IL1B in LPS plus IFNG-stimulated macrophages; via MAS1
117283 Angiotensin (1-7) decreases_activity of inflammatory response in LPS plus IFNG-stimulated macrophages; via MAS1
30918468 Lung disease
11,928
117302 Angiotensin (1-7) increases_activity of MAS1 in HEK293 cells
117307 Angiotensin (1-7) increases_activity of MRGPRD in HEK293 cells
117308 Angiotensin (1-7) increases_activity of Protein kinase A in HUVECs
27217404 Cardiovascular disease
11,929
117303 Angiotensin (1-7) increases_quantity of cAMP in the cell, in vascular smooth muscle cells, in mesangial cells
27217404 Cardiovascular disease
11,933
117315 Angiotensin (1-7) interacts (colocalizes) with AGTR2 in HEK293 cells
21542804 Cardiovascular disease
11,935
117317 Angiotensin (1-7) NOT interacts (colocalizes) with MAS1
117359 Angiotensin (1-7) decreases_activity of AGTR1
29928987 Cardiovascular disease
11,936
117318 Angiotensin (1-7) increases_activity of MAS1 in kidney
117360 Angiotensin (1-7) increases_activity of arachidonic acid secretion
12829792 Cardiovascular disease
11,937
117364 Angiotensin (1-7) increases_expression of CX3CR1
28461604 Cardiovascular disease
12,009
117645 FGF21 increases_quantity of Angiotensin (1-7) in adipose tissue, in kidney; via ACE2
29706566 Cardiovascular disease
12,020
117800 ACE decreases_quantity of Angiotensin (1-7)
117804 Angiotensin (1-7) increases_activity of vasodilation
30934934 Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
12,022
117883 ACE2 increases_quantity of Angiotensin (1-7) counterbalancing the effects of RAS via conversion of Ang II to Ang-(1-7)
30604460 Metabolic
Fatty liver disease, nonalcoholic
-->